Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1987-10-21
2010-11-23
Rawlings, Stephen L (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023500, C536S024310, C530S350000, C530S387100, C530S387700, C530S387900, C435S007100, C436S064000
Reexamination Certificate
active
07838216
ABSTRACT:
The isolation, cloning and characterization of a human gene related to but distinct from EGF receptor gene has been described. Nucleotide sequence of the gene and amino acid sequence of the polypeptide encoded by the gene have been determined. The use of the nucleic acid probes and antibodies having specific binding affinity with said polypeptide for diagnostic and therapeutic purposes have also been described.
REFERENCES:
patent: 4968603 (1990-11-01), Slamon et al.
Sedlak (1994) Genetic Engineering News of May 15, 1994, pp. 8-9.
Brison (1993) Biochimica et Biophysica Acta, vol. 1155, pp. 25-41.
Semba et al. (1985) Proc. Natl Acal Sci (USA), vol. 82, pp. 6497-6501.
Yamamoto et al. (1986) Nature, vol. 319, pp. 230-234.
Southern (J. Mol. Biol. Nov. 5, 1975; 98 (3): 503-517).
Bergmann et al. (J. Virol. Sep. 1980;35 (3): 968-971).
Coussens et al. (Science. Dec. 6, 1985; 230: 1132-1139).
Scott et al. (Mol. Cell. Biol. Apr. 1993; 13 (4): 2247-2257).
Aigner et al. (Oncogene. Apr. 19, 2001; 20 (17): 2101-2111).
Doherty et al. (Proc. Natl. Acad. Sci. U S A. Sep. 14, 1999; 96 (19): 10869-10874).
Koletsa et al. (Neoplasia. Jul. 2008; 10 (7): 687-696).
Harris et al. (J. Am. Soc. Nephrol. 1995; 6: 1125-1133).
Ahn et al. (Nature Gen. 1993; 3: 283-291).
Cawthon et al. (Genomics 1991; 9: 446-460).
Ward (Developmental Oncology 1985; 21: 91-106).
Yokata et al. (Lancet. Apr. 5, 1986; 1 (8484): 765-767).
Critchfield (Disease Markers 1999; 15: 108-111).
Sidransky (Science 1997; 278: 1054-1058).
Tockman et al. (Cancer Research 1992; 52: 2711s-2718s).
Slamon et al. (Science. Jan. 9, 1987; 235: 177-182).
Kim et al. (J. Korean Med. Sci. Jun. 2008; 23 (3): 414-420).
Roessler et al. (Mol. Cell. Prot. 2006; 5 (11): 2092-2101).
Roessler et al. (Clin. Can. Res. 2005; 11 (18): 6550-6557).
Zolg et al. (Mol. Cell. Prot. 2004; 3 (4): 345-354).
Leitzel et al. (J. Clin. Oncol. Sep. 1992; 10 (9): 1436-1443).
Kath et al. (Ann. Oncol. Aug. 1993; 4 (7): 585-590).
King et al. (Science. Sep. 6, 1985; 229: 974-976).
Semba et al. (Proc. Natl. Acad. Sci. USA. Oct. 1985; 82: 6497-6501).
Montgomery et al. (Proc. Natl. Acad Sci. U S A. Sep. 1983; 80 (18): 5724-5728).
Brison et al. (Biochim. Biophys. Acta. May 25, 1993; 1155 (1): 25-41).
Kozbor et al. (Cancer Res. Feb. 1984; 44 (2): 438-441).
Filmus et al. (Biochem. Biophys. Res. Commun. Apr. 30, 1985; 128 (2): 898-905).
Yander et al. (Cancer Res. Sep; 45 (9): 4433-4438).
Kohl et al. (Cell. Dec. 1983; 35 (Pt 1): 359-367).
Land et al.,Science 222:771-778, 1983.
Cohen, et al.,J. Biol. Chem 255:4834-4842, 1980.
Nishimura, et al.Proc. Natl. Acad. Sci. USA 79:4303-4307, 1982.
Kasuga et al.Nature 298:667-669, 1982.
Rubin, et al.Nature 305:438-440, 1983.
Yamamoto, et al.Cell 35:71-78, 1983.
de Klein, et al.,Nature 300:765, 1982.
Collins, et al.Proc. Natl. Acad. Sci. USA 80:4813, 1983.
Liberman, et al.,Nature 313:144, 1985.
Lin, et al.Science 224:843, 1984.
Rigby, et al.,J. Mol. Biol. 113:237, 1977.
Wahl, et al.Proc. Natl. Acad. Sci USA 76:3683-3687, 1979.
Downward, et al.Nature 307:521-527, 1984.
Ullrich, et al.,Nature 309:418-425, 1984.
Doolittle, et al.Science 221:275-277, 1983.
King et al., Amplification of a Novel v-erbB-Related Gene in a Human Mammary Carcinoma,Science, (1985) 229:974-976.
Kraus et al., Overexpression of the EGF Receptor-Related Proto-Oncogene erbB-2 in Human Mammary Tumor Cell Lines . . .The EMBO Journal, (1987) 6:605-610.
Di Foire et al., erbB-2 Is A Potent Oncogene when Overexpressed in NIH/3T3 Cells,Science.,(1987) 237:178-182.
Lacroix et al., Overexpression of erbB-2 or EGF Receptor Proteins Present In Early Stage Mammary . . .Oncogene, (1989) 4:145-151.
Slamon et al., Human Breast Cancer: Correlation of Relapse and Survival with . . . ,Science, (1987), 235:177-182.
A. Ullrich et al., “Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells,” Nature (1984) vol. 309, pp. 418-425.
Paik, S. et al. “Pathologic Findings From the National Surgical Adjuvant Breast and Bowel Project: Prognostic Significance of erbB-2 Protein Overexpression in Primary Breast Cancer” J. of Clinical Oncology (1990) 8:103-112.
King, C.R. et al. “Heterogeneous Expression of erbB-2 Messenger RNA in Human Breast Cancer” Cancer Research(1989) 49:4185-4191.
Park, J-B. et al. “Amplification, Overexpression, and Rearrangement of erbB-2 Protooncogene in Primary Human Stomach Carcinomas” Cancer Research (1989) 49:6605-6609.
King, C.R. et al. “Implications of erbB-2 overexpression for basic science and clinical medicine” seminars in Cancer Biology (1990) 1:329-337.
Berger. M.S. et al. “Correlation of c-erbB-2 Gene Amplification and Protein Expression in Human Breast Carcinoma with Nodal Status and Nuclear Grading” Cancer Research (1988) 48:1238-1243.
Aaronson Stuart A.
King C. Richter
Kraus Matthias H.
Rawlings Stephen L
Rucker Susan S.
Sheridan & Ross P.C.
The United States of America as represented by the Department o
LandOfFree
Human gene related to but distinct from EGF receptor gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human gene related to but distinct from EGF receptor gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human gene related to but distinct from EGF receptor gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4239399